About Professor Birkmayer

In the last decades Professor George Birkmayer was considered the world's leading expert on NADH and its therapeutic applications. His experience with NADH in therapeutic form dates back to 1987 and since that date he continuously improved his formulations for stabilized NADH and explored the fields of its applications. His expertise in the field of cellular metabolism dates back to his studies of biochemistry, in which he earned a PhD from the University of Vienna in 1968. He has spent most of his career in research alongside the leading figures of the field, including an extended research fellowship with Professor Bishop in the department of microbiology at the University of California in San Francisco. As an assistant professor for Cell Biology in Munich he simultaneously graduated his medical training at the University of Munich in 1979. He was appointed Professor for Medical Chemistry at the University of Graz in 1988 and remained active as a professor, but also as a researcher in the fields of oncology, neurology and anti-aging medicine, always seeking answers in the underlying biochemistry of the human body and its systems. He has been invited to lectures in all parts of the world. Ever since his groundbreaking discovery, he focused most of his efforts on the exploration of applications of his formulation for stabilized NADH. Professor Birkmayer died on August 28th 2022.